Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer

Patricia V. Schoenlein, Min Hou, Julia S. Samaddar, Virgil T. Gaddy, Muthusamy Thangaraju, Jill Lewis, Maribeth Johnson, Vadivel Ganapathy, Andre Kallab, John T. Barrett

Research output: Contribution to journalArticle

14 Scopus citations

Fingerprint Dive into the research topics of 'Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences